Lewis H. Titterton Jr. - 24 Jun 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Issuer symbol
ANIX
Transactions as of
24 Jun 2022
Net transactions value
+$118,450
Form type
4
Filing time
28 Jun 2022, 10:21:32 UTC
Previous filing
27 Apr 2022
Next filing
16 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $77,250 +30,000 +3% $2.58 1,018,070 24 Jun 2022 Direct
transaction ANIX Common Stock Options Exercise $41,200 +16,000 +1.6% $2.58 1,034,070 24 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Options Exercise $0 -30,000 -100% $0.000000* 0 24 Jun 2022 Common Stock 30,000 $2.58 Direct F1
transaction ANIX Employee Stock Option Options Exercise $0 -16,000 -100% $0.000000* 0 24 Jun 2022 Common Stock 16,000 $2.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, pursuant to a stock option grant dated September 19, 2012.
F2 Right-To-Buy, pursuant to a stock option grant dated March 28, 2013.